JP2013529080A5 - - Google Patents

Download PDF

Info

Publication number
JP2013529080A5
JP2013529080A5 JP2013510643A JP2013510643A JP2013529080A5 JP 2013529080 A5 JP2013529080 A5 JP 2013529080A5 JP 2013510643 A JP2013510643 A JP 2013510643A JP 2013510643 A JP2013510643 A JP 2013510643A JP 2013529080 A5 JP2013529080 A5 JP 2013529080A5
Authority
JP
Japan
Prior art keywords
dom7h
seq
variant
variable domain
single variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013510643A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013529080A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/058298 external-priority patent/WO2011144751A1/en
Publication of JP2013529080A publication Critical patent/JP2013529080A/ja
Publication of JP2013529080A5 publication Critical patent/JP2013529080A5/ja
Pending legal-status Critical Current

Links

JP2013510643A 2010-05-20 2011-05-20 改良された抗血清アルブミン結合変異体 Pending JP2013529080A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34651910P 2010-05-20 2010-05-20
US61/346,519 2010-05-20
PCT/EP2011/058298 WO2011144751A1 (en) 2010-05-20 2011-05-20 Improved anti-serum albumin binding variants

Publications (2)

Publication Number Publication Date
JP2013529080A JP2013529080A (ja) 2013-07-18
JP2013529080A5 true JP2013529080A5 (cg-RX-API-DMAC7.html) 2014-07-03

Family

ID=44352234

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013510643A Pending JP2013529080A (ja) 2010-05-20 2011-05-20 改良された抗血清アルブミン結合変異体

Country Status (13)

Country Link
US (2) US9040668B2 (cg-RX-API-DMAC7.html)
EP (1) EP2571900A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013529080A (cg-RX-API-DMAC7.html)
KR (1) KR20130109977A (cg-RX-API-DMAC7.html)
CN (1) CN103003303A (cg-RX-API-DMAC7.html)
AU (1) AU2011254559B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012029280A2 (cg-RX-API-DMAC7.html)
CA (1) CA2799633A1 (cg-RX-API-DMAC7.html)
EA (1) EA201291009A1 (cg-RX-API-DMAC7.html)
IL (1) IL222802A0 (cg-RX-API-DMAC7.html)
MX (1) MX2012013406A (cg-RX-API-DMAC7.html)
SG (1) SG185437A1 (cg-RX-API-DMAC7.html)
WO (1) WO2011144751A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
CA2895875A1 (en) 2012-12-21 2014-06-26 Sanofi Exendin-4 derivatives
EP3080154B1 (en) 2013-12-13 2018-02-07 Sanofi Dual glp-1/gip receptor agonists
WO2015086730A1 (en) 2013-12-13 2015-06-18 Sanofi Non-acylated exendin-4 peptide analogues
EP3080150B1 (en) 2013-12-13 2018-08-01 Sanofi Exendin-4 peptide analogues as dual glp-1/gip receptor agonists
WO2015086733A1 (en) 2013-12-13 2015-06-18 Sanofi Dual glp-1/glucagon receptor agonists
TW201625670A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自exendin-4之雙重glp-1/升糖素受體促效劑
TW201625668A (zh) 2014-04-07 2016-07-16 賽諾菲公司 作為胜肽性雙重glp-1/昇糖素受體激動劑之艾塞那肽-4衍生物
TW201625669A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自艾塞那肽-4(Exendin-4)之肽類雙重GLP-1/升糖素受體促效劑
US9932381B2 (en) 2014-06-18 2018-04-03 Sanofi Exendin-4 derivatives as selective glucagon receptor agonists
AR105319A1 (es) 2015-06-05 2017-09-27 Sanofi Sa Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
AR105284A1 (es) 2015-07-10 2017-09-20 Sanofi Sa Derivados de exendina-4 como agonistas peptídicos duales específicos de los receptores de glp-1 / glucagón
PL3374392T3 (pl) * 2015-11-13 2022-03-28 Ablynx Nv Ulepszone domeny zmienne immunoglobuliny wiążące albuminę surowicy
KR102533456B1 (ko) 2016-05-18 2023-05-17 모더나티엑스, 인크. 릴랙신을 인코딩하는 폴리뉴클레오타이드
WO2024170756A1 (en) 2023-02-17 2024-08-22 Ablynx N.V. Polypeptides binding to the neonatal fc receptor
WO2025021183A1 (zh) * 2023-07-27 2025-01-30 上海复宏汉霖生物医药有限公司 编码促肾上腺皮质激素的多核苷酸及其相关组合物和方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
DK1517921T3 (da) 2002-06-28 2006-10-09 Domantis Ltd Immunglobulin-enkeltvariable antigen-bindende domæner og dobbeltspecifikke konstruktioner deraf
US20060002935A1 (en) 2002-06-28 2006-01-05 Domantis Limited Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
US9321832B2 (en) 2002-06-28 2016-04-26 Domantis Limited Ligand
EP1737962B1 (en) 2004-03-24 2010-09-01 Domantis Limited Gas1 universal leader
JP2008500830A (ja) 2004-06-01 2008-01-17 ドマンティス リミテッド 増加した血清半減期を有する二重特異性融合抗体
WO2006059106A2 (en) 2004-12-02 2006-06-08 Domantis Limited Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
WO2007085814A1 (en) 2006-01-24 2007-08-02 Domantis Limited Fusion proteins that contain natural junctions
JP2010528647A (ja) 2007-06-06 2010-08-26 ドマンティス リミテッド ポリペプチド、抗体可変ドメインおよびアンタゴニスト
GB0724331D0 (en) * 2007-12-13 2008-01-23 Domantis Ltd Compositions for pulmonary delivery
MX2009013137A (es) * 2007-06-06 2010-04-30 Domantis Ltd Metodos para seleccionar polipeptidos resistentes a la proteasa.
EA023031B1 (ru) 2007-11-30 2016-04-29 Глаксо Груп Лимитед Антиген-связывающая конструкция и ее применение
AR075505A1 (es) * 2009-02-19 2011-04-06 Glaxo Group Ltd Variantes de union a anti- albumina de suero mejoradas
PE20120170A1 (es) * 2009-02-19 2012-03-21 Glaxo Group Ltd Variantes de union a anti-albumina de suero mejoradas
AU2010215479B2 (en) * 2009-02-19 2015-01-22 Glaxo Group Limited Improved anti-TNFR1 polypeptides, antibody variable domains & antagonists
KR20110137819A (ko) * 2009-03-27 2011-12-23 글락소 그룹 리미티드 약물 융합체 및 컨쥬게이트
WO2011006914A2 (en) * 2009-07-16 2011-01-20 Glaxo Group Limited Antagonists, uses & methods for partially inhibiting tnfr1
CN102666586A (zh) * 2009-09-30 2012-09-12 葛兰素集团有限公司 具有延长的半衰期的药物融合体和缀合物

Similar Documents

Publication Publication Date Title
JP2013529080A5 (cg-RX-API-DMAC7.html)
CN110191896B (zh) 改进的血清白蛋白结合物
JP2023027258A (ja) 改善された血清アルブミン結合性免疫グロブリン可変ドメイン
CN110049997B (zh) 改进的血清白蛋白结合免疫球蛋白单可变结构域
CN110461870B (zh) 改进的血清白蛋白结合物
CN103619878B (zh) 结合血清白蛋白的蛋白
JP2009545319A5 (cg-RX-API-DMAC7.html)
JP2013538566A5 (cg-RX-API-DMAC7.html)
JP2017506075A5 (cg-RX-API-DMAC7.html)
JP2017527272A5 (cg-RX-API-DMAC7.html)
JP2014513953A5 (cg-RX-API-DMAC7.html)
JP2010502183A5 (cg-RX-API-DMAC7.html)
JP2013518853A (ja) 血清アルブミンと結合することが可能なペプチド並びにこれを含む化合物、構築物及びポリペプチド
JP2017500018A5 (cg-RX-API-DMAC7.html)
CN108473564A (zh) 改进的血清白蛋白结合剂
JP2018526989A5 (cg-RX-API-DMAC7.html)
CN115397852B (zh) 工程化抗il-2抗体
JP2009539349A5 (cg-RX-API-DMAC7.html)
JP2020521458A5 (cg-RX-API-DMAC7.html)
JP2018113988A (ja) IL−1βへの結合メンバー
JP2010535032A5 (cg-RX-API-DMAC7.html)
JP2009528828A5 (cg-RX-API-DMAC7.html)
EA034854B1 (ru) Анти-il-17-антитела, способ их получения и способ применения
JP2013543384A5 (cg-RX-API-DMAC7.html)
JP2018535972A5 (cg-RX-API-DMAC7.html)